Chinese Journal of Blood Purification ›› 2017, Vol. 16 ›› Issue (05): 289-292.doi: 10.3969/j.issn.1671-4091.2017.05.001

    Next Articles

Concern for the diagnosis and treatment of pulmonary arterial hypertension in hemdialysis patients

  

  • Received:2017-02-10 Online:2017-05-12 Published:2017-05-19

Abstract: Pulmonary arterial hypertension (PAH) is a chronic and progressive disease leading to right heart failure and death if untreated. It is a common abnormality in patients with dialysis-dependent chronic kidney disease, especially those having arteriovenous fistula. With the increase of chronic kidney disease patients, the prevalence of severe PAH and the mortality of cardiac diseases are significantly increasing. Several factors cause the development and progression of PAH. Clinically, PAH should be identified and treated earlier to mitigate the susceptible factors and to prevent the development of PAH.

Key words: Pulmonary arterial hypertension (PAH), Hemodialysis, Pathogenesis, Therapy